| Non-cluster Patients (193 = 74.8%) | Cluster patients (65; 25%) | ||
---|---|---|---|---|
Nationality | Iranian 151(78.2%) | Afghani 42(21.3%) | Iranian 48(73%) | Afghani 17(26%) |
Mean age | 47.91 ± 25 | 39.65 ± 11 | 44.17 ± 19 | 36.19 ± 8 |
Female | 70(46.3%) | 15(35.7%) | 18(37.5%) | 8(47%) |
Male | 81(53.6%) | 27(64.2%) | 30(62.5%) | 9(56.9%) |
Pulmonary | 147 (97.3%) | 37(88%) | 47(97.9.%) | 14(46.4%) |
Extra-pulmonary | 2(1.3%) | 3(7.1%) | 0 | 2 (30.7%) |
Both | 2 (1.3%) | 2(4.7%) | 1(2.0%) | 1(1.5%) |
AIDS | 2(1.3%)Positive | 17 (40.4%) Negative | 3(6.25) Negative | 17(26.1%) NA |
 | 76(97.5%) Negative | 25(59.5%)NA | 41(85.4%) NA |  |
 | 73(48.3%) NA |  |  |  |
PPD | 72(47%) Positive | 16(38%) Positive | 19(39.5%) Positive | 4(23%) Positive |
 | 18 (11.9%) Negative | 5 (11.9%) Negative | 8 (16.6%) Negative | 3 (7.6%) Negative |
 | 25(16.5%)equivocal | 9(21.9%)equivocole | 14 (29.1%)equivocole | 7(11%) equivocole |
 | 36(23.8%) NA* | 12(28.5%) NA | 7(14.5%) NA | 5(29.4%) NA |
History of family or close contact | 27(17.8%) | 17(40%) | 10 (20.8%) | 8(47.9%) |
 | 96(63.5%) | 5(11.9%) | 35 (72.9%) | 8(33%) |
Susceptible | 29(19.2%) | 31 (73.8%) | 5(10.4%) | 7(41.1%) |
MDR-Other resistant | 26(17.2%) | 6(14.2%) | 8 (16.6%) | 2(11.7%) |
Crowded and low living condition | 134(88.7%) | 38 (90%) | 44 (91.6%) | 17(100%) |
Low-Salary | 129(85.4%) | 40(95.2%) | 35(72.9%) | 16(94.1%) |